Doctor profile · Federal record

Dr. Sumalatha Patibandla, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Medical Oncology Physician · Beaumont, TX

  • NPI 1699713198
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 30 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
3070 College St, Suite 301
Beaumont, TX 777014691
(409) 813-1686
fax (409) 813-3052
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
April 12, 2017
Year of graduation
1996 — 30 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Texas #L7102
Medicaid (4)
TX #514019YZ21 · TX #159914401 · TX #159914402 · TX #159914403

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1699713198. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
38,900
Distinct HCPCS
10
Medicare allowed
$650,896
HCPCS Description Services Patients Avg allowed
J1756 Injection, iron sucrose, 1 mg 14,700 41 $0
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 8,920 20 $3
J9271 Injection, pembrolizumab, 1 mg 6,000 12 $54
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,393 35 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,105 329 $8
80053 Blood test, comprehensive group of blood chemicals 957 328 $10
99214 Established patient office or other outpatient visit, 30-39 minutes 717 261 $120
83615 Lactate dehydrogenase (enzyme) level 472 289 $6
36415 Insertion of needle into vein for collection of blood sample 467 190 $8
83735 Magnesium level 423 49 $7

In context: peer comparison

Among 2 peers in Beaumont Hematology & Oncology Physician, average services per provider: 1,328. This provider delivers 29× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$762
Transactions
27
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Boston Scientific Corporation 1 $83.54
Sobi, INC 2 $80.96
Pfizer INC. 4 $79.15
Boehringer Ingelheim Pharmaceuticals, INC. 3 $68.11
Eisai INC. 3 $58.94
Genzyme Corporation 2 $52.18
Gilead Sciences, INC. 2 $49.52
Puma Biotechnology, INC. 2 $40.61
Janssen Biotech, INC. 2 $31.59
Tempus Ai, INC 1 $28.87
AstraZeneca Pharmaceuticals Lp 1 $27.89
PharmaEssentia USA Corporation 1 $27.85
Celgene Corporation 1 $23.77
Genmab U.S., INC. 1 $22.68
Taiho Oncology, INC. 1 $21.06

By nature of payment

Food and Beverage
$762

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
655
Patients
212
Total drug cost
$517,052
Drug Type Claims Patients Total cost
Anastrozole Generic 148 46 $4,081
Potassium Chloride Generic 62 38 $463
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 58 16 $2,622
Hydroxyurea Generic 57 16 $2,208
Eliquis (Apixaban) Brand 53 12 $41,271
Levofloxacin Generic 40 29 $229
Ondansetron Hcl Generic 34 15 $351
Letrozole Generic 33 0 $845
Azithromycin Generic 32 24 $157
Folic Acid Generic 30 0 $105

Frequently asked questions

Auto-generated from federal data
What is Dr. Sumalatha Patibandla's medical specialty?
Dr. Sumalatha Patibandla practices Hematology & Oncology Physician in Beaumont, TX.
Where does Dr. Sumalatha Patibandla practice?
Dr. Sumalatha Patibandla practices at 3070 College St, Beaumont, TX 777014691. Office phone: 4098131686.
What is Dr. Sumalatha Patibandla's NPI?
Dr. Sumalatha Patibandla's National Provider Identifier (NPI) is 1699713198, issued by NPPES.
Does Dr. Sumalatha Patibandla accept Medicare assignment?
Yes. Dr. Sumalatha Patibandla accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sumalatha Patibandla commonly perform?
Top Medicare-reported procedures in 2023: Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.